Biofrontera AG Sustainability Reports
Biofrontera AG develops and commercializes dermatological drugs and medical devices for the treatment of skin diseases and conditions.
Sector: Health Care
Country: Germany
Exchange: Deutsche Borse Xetra
ISIN: DE000A4BGGM7
24 reports from 2013 to 2025
- Biofrontera AG 2025 Combined Management Report and Group Management Report
- Biofrontera AG 2024 Combined Management Report and Group Management Report
- Biofrontera AG 2024 Declaration on Corporate Governance
- Biofrontera AG 2024 Annual Report
- Biofrontera AG 2023 Combined Management Report and Group Management Report
Company Profile
Biofrontera AG
Biofrontera AG develops and commercializes dermatological drugs and medical devices for the treatment of skin diseases and conditions.
Reports